Immediate Impact
12 by Nobel laureates 23 from Science/Nature 60 standout
Citing Papers
Pharmacology and Clinical Development of Factor XI Inhibitors
2023 Standout
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
2020 Standout
Works of Maxwell D. Cummings being referenced
Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor
2014
Induced‐Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Maxwell D. Cummings | 1545 | 451 | 433 | 670 | 568 | 52 | 2.8k | |
| M.M. Cherney | 1893 | 227 | 351 | 776 | 360 | 75 | 3.4k | |
| Priscilla L. Yang | 2238 | 777 | 377 | 875 | 581 | 48 | 4.6k | |
| Magali Mathieu | 1494 | 200 | 312 | 594 | 218 | 37 | 3.0k | |
| Hans E. Parge | 2024 | 549 | 584 | 373 | 428 | 44 | 3.7k | |
| Kent D. Stewart | 1251 | 460 | 295 | 553 | 953 | 90 | 3.1k | |
| Paul R. Caron | 3932 | 479 | 716 | 426 | 260 | 39 | 5.2k | |
| Krzysztof Appelt | 2211 | 589 | 69 | 717 | 727 | 85 | 3.9k | |
| Warren M. Kati | 1595 | 173 | 722 | 1373 | 655 | 80 | 3.4k | |
| Tarek S. Mansour | 2217 | 432 | 326 | 580 | 2391 | 147 | 4.9k | |
| Paula M.D. Fitzgerald | 1456 | 303 | 41 | 990 | 624 | 37 | 2.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...